Journal of Developing Drugs
Open Access
ISSN: 2329-6631
+44 1478 350008
ISSN: 2329-6631
+44 1478 350008
David Spaulding
SeerPharma, Australia
Keynote: J Develop Drugs
Training is a GMP requirement, but poor training is draining on a business. By understanding stages of learning, we can develop training programs tailored to trainee needs to improve the effectiveness of training and its value to the business. Even the best training programs aren��?t enough on their own and errors will still occur. Re-training has a place in GMP operations but with a greater understanding of human error, we can apply other initiatives to reduce defects and avoid wasted resources of re-training; a common problem for the industry.
David Spaulding is Senior Consultant and Training Manager for SeerPharma, one of Asia-Pacific’s largest providers of QA/GMP Training and Consulting services to Pharmaceutical and Medical Device Manufacturers. He has worked in various roles within the Pharmaceutical Industry for over 30 years from R&D, Production, Sales and Marketing to CEO of an Australian pharmaceutical company for over 5 years. In his current role, he oversees SeerPharma’s Training Division, including our collaboration with the University of Technology Sydney, to offer Asia-Pacific’s sole Postgraduate course on Good Manufacturing Practice (GMP). He holds an Honor’s Degree in Chemistry from Monash University and a Diploma in Business Administration from Swinburne University of Technology.